Acuta Capital Partners, LLC Concert Pharmaceuticals, Inc. Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$4.86 - $13.07 $2.61 Million - $7.03 Million
-537,500 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$9.48 - $12.84 $2.25 Million - $3.05 Million
237,500 Added 79.17%
537,500 $6.79 Million
Q3 2020

Nov 16, 2020
BUY
$8.67 - $10.82 $2.6 Million - $3.25 Million
300,000 New
300,000 $2.95 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email